Biogen R&D Day to Provide Overview of Diversified Pipeline and Capabilities with Potential for Multiple Novel Therapies in Neuroscience
33 early and late-stage clinical programs across modalities and innovative discovery platformsUniquely positioned to lead in Alzheimer’s disease with ADUHELM®...